References - Therapeutic Strategies in Cancer Biology and Pathology - page 265

Zhou, R.H., Kokame, K., Tsukamoto, Y., Yutani, C., Kato, H., Miyata, T., 2001.
Characterization of the human NDRG gene family: a newly identified member, NDRG4,
is specifically expressed in brain and heart. Genomics 73, 86-97.
Zhou, W.H., Tang, F., Xu, J., Wu, X., Feng, Z.Y., Li, H.G., et al., 2011b. Aberrant upregula-
tion of 14-3-3o' expression serves as an inferior prognostic biomarker for gastric cancer.
BMC Cancer 11, 397.
Zhou, X., Thorgeirsson, S.S., Popescu, N.C., 2004. Restoration of DLC-1 gene expression
induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocel-
lular carcinoma cells. Oncogene 23, 1308-1313.
Zhou, X., Zhang, J., Jia, Q., Ren, Y., Wang, Y., Shi, L., et al., 2010b. Reduction of miR-21
induces glioma cell apoptosis via activating caspase 9 and 3. Oncol. Rep. 24, 195-201.
Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M.S., Yang, X., 2011c. TAZ is a novel oncogene
in non-small cell lung cancer. Oncogene 30, 2181-2186.
Zhu, C.H., Cheng, K.W., Ouyang, N.T., Huang, L.Q., Sun, Y., Constantinides, P., et al., 2012.
Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in
human breast cancer xenografts. Stem Cells 30, 2065-2075.
Zhu, H., Wu, H., Liu, X., Evans, B.R., Medina, D.J., Liu, C.G., et al., 2008a. Role of
MicroRNA miR-27a and miR-451 in the regulation of MDR1/P glyglycoprotein expres-
sion in human cancer cells. Biochem. Pharmacol. 76, 582-588.
Zhu, J., Shimizu, E., Zhang, X., Partridge, N.C., Qin, L., 2011. EGFR signaling suppresses
osteoblast differentiation and inhibits expression of master osteoblastic transcription fac-
tors Runx2 and Osterix. J. Cell. Biochem. 112, 1749-1760.
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., Mo, Y.Y., 2008b. MicroRNA-21 targets tumor sup-
pressor genes in invasion and metastasis. Cell Res. 18, 350-359.
Zhu, Z., Luo, Z., Li, Y., Ni, C., Li, H., Zhu, M., 2009. Human inhibitor of growth 1 inhib-
its hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Hepatology 49, 504-512.
Zhuang, Z.G., Di, G.H., Shen, Z.Z., Ding, J., Shao, Z.M., 2006. Enhanced expression of
LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.
Mol. Cancer Res. 4, 843-849.
Zou, Z.Q., Gao, C.L., Nagaich, A.K., Connell, T., Saito, S., Moul, J.W., et al., 2000. p53
regulates the expression of the tumor suppressor gene maspin. J. Biol. Chem. 275,
6051-6054.
Zuo, J.H., Zhu, W., Li, M.Y., Li, X.H., Yi, H., Zeng, G.Q., et al., 2011. Activation of EGFR
promotes squamous carcinoma SCC10A cell migration and invasion via inducing
EMT-Like phenotype change and MMP-9-mediated degradation of E-cadherin. J. Cell.
Biochem. 112, 2508-2517.